InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Miller Ann Calby, Director. Director active across 3 companies, notably INOVIO PHARMACEUTICALS, INC.. Cumulatively, 8 filings have been recorded. Total volume traded: €242k. The latest transaction was disclosed on 15 June 2021 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
18,000 shares
Common Stock
SEC:0001055726-22-000037:0·
4,273 shares
Common Stock
SEC:0001055726-22-000026:0·
027,858 shares0
COMMON STOCK
SEC:0001209191-21-041787·
027,858 shares0
COMMON STOCK
SEC:0001209191-21-041787:0·
€120,89212,874 shares@ €9.39040.034% mcap50.0% of flow
COMMON STOCK
SEC:0001209191-21-039897:0·
€120,89212,874 shares@ €9.39040.034% mcap100.0% of flow
COMMON STOCK
SEC:0001209191-21-039897·
8,700 shares
Common Stock
SEC:0001055726-21-000048·
8,700 shares
Common Stock
SEC:0001055726-21-000048:0·
8 of 8 declarations
About Miller Ann Calby
Ann Calby Miller is a Board Member at INOVIO Pharmaceuticals, Inc. and PUMA Biotechnology, Inc. She brings significant expertise in corporate governance and business strategy. Her role involves overseeing operations and guiding strategic decisions to ensure the growth and sustainability of the companies. Miller is valued for her ability to combine innovation with accountability in the biopharmaceutical sector.
